Daniel F. Cain

Director, Repros Therapeutics.

Companies

Repros TherapeuticsBoard member May 4, 2006 to Jan 31, 2018¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRepros Therapeutics, Board member